Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001745020-18-000001
Filing Date
2018-06-29
Accepted
2018-06-29 13:30:31
Documents
1
Effectiveness Date
2018-06-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6558
  Complete submission text file 0001745020-18-000001.txt   7664
Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE., FL 54 NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE., FL 54 NEW YORK NY 10022 2127396493
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

EIN.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-315789 | Film No.: 18928541